Prevalence and Affecting Factors of Sleep and Circadian Rhythm Disorders in ICU
Launched by SHANGHAI ZHONGSHAN HOSPITAL · Apr 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how common sleep problems and disruptions in daily rhythms (known as circadian rhythms) are in patients who are in the Intensive Care Unit (ICU). Many patients in the ICU struggle with sleep, which can lead to serious issues like longer time on breathing machines, problems with blood sugar levels, and confusion (delirium). The researchers want to understand how often these sleep issues happen and what factors might contribute to them. This information will help develop better ways to support patients' sleep and overall health in the ICU.
To join the study, participants must be adults over 18 years old who are admitted to the ICU between 8 AM and 10 PM and stay for at least 12 hours, including one overnight stay. They should also be able to agree to participate or have a family member who can give consent. However, individuals with certain conditions, like recent serious brain injuries, severe cognitive issues, or those who are pregnant, cannot participate. If you or a loved one meet the criteria and choose to join, you will help researchers gather important information that could improve the care of future ICU patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult patients older than 18 years old.
- • 2. Patients transferred to ICU during the time period of 8:00-22:00.
- • 3. Stay in the ICU for more than 12 hours and at least one overnight period.
- • 4. Patients or their family members are informed and consent to participate in the research.
- Exclusion Criteria:
- • 1. Acute brain injuries within 30 days, such as acute intracranial bleeding, traumatic brain injury, central nervous system infection, or chronic brain injuries lasting over 30 days with an inability to live independently.
- • 2. Previously diagnosed with mild cognitive impairment or Alzheimer's disease.
- • 3. Patients affected by blindness or optic nerve disorder.
- • 4. Patients who are pregnant or breastfeeding.
- • 5. Patient in prone position, hemodialysis, or ECMO therapy during PSG monitoring
- • 6. Imminently dying or with a hospice status.
About Shanghai Zhongshan Hospital
Shanghai Zhongshan Hospital is a prestigious medical institution affiliated with Fudan University, renowned for its commitment to advancing healthcare through rigorous clinical research and innovative patient care. With a focus on multidisciplinary collaboration and cutting-edge medical technologies, the hospital conducts a wide range of clinical trials aimed at improving treatment outcomes across various specialties. Its state-of-the-art facilities and highly qualified research team ensure that trials adhere to the highest ethical and scientific standards, contributing significantly to the global body of medical knowledge and enhancing patient health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Trial Officials
YuXia Zhang, PhD
Study Director
Fudan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported